Cargando…
What Underlies the Benefit of Famotidine Formulations Used During COVID-19?
Autores principales: | Singh, Vijay P., El-Kurdi, Bara, Rood, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411504/ https://www.ncbi.nlm.nih.gov/pubmed/32777281 http://dx.doi.org/10.1053/j.gastro.2020.07.051 |
Ejemplares similares
-
Mechanistic basis and therapeutic relevance of hypocalcemia during severe COVID-19 infection
por: Singh, Vijay P., et al.
Publicado: (2020) -
Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021) -
Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021) -
Association Between Famotidine Use and COVID-19 Severity in Hong Kong: A Territory-wide Study
por: Cheung, Ka Shing, et al.
Publicado: (2021) -
Hypocalcemia and hypoalbuminemia during COVID-19 infection: Opportunities for therapeutic intervention
por: Singh, Vijay P., et al.
Publicado: (2020)